MedCity News October 12, 2021
Bionano Genomics is acquiring genomics software firm BioDiscovery in a $90 million cash and stock deal. While both companies provide genomics analysis solutions, Bionano said combining its technology with BioDiscovery’s software will provide the integrated offering that many labs want.
Bionano Genomics, which has commercialized a genome analysis platform used in laboratories across the world, is acquiring software firm BioDiscovery in a $90 million deal intended to broaden the reach of its technology, the company announced Tuesday.
The technology of San Diego-based Bionano technology offers what’s called optical genome mapping, which is an analysis of the genome that reveals structural variations in the DNA of one person compared to another. These structural variations can cause disease. Scientists and clinicians use...
Today's Sponsors
Today's Sponsor